The Icahn School of Medicine at Mount Sinai, a top-ranked academic medical center in New York City, and National Jewish Health, the nations leading respiratory hospital based in Denver, Colorado, have partnered to create the Mount Sinai – National Jewish Health Respiratory Institute. Combining the strengths of both entities into an integrated Respiratory Institute brings together leading expertise in diagnosing and treating all forms of respiratory illness and lung disease, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD) and bronchiectasis. The Respiratory Institute creates new options for patients in New York City and the surrounding region. Through the integration of research advances, clinical skill and patient-focused processes and protocols, the Respiratory Institute offers a model for the state-of-the-art delivery of multidisciplinary, outcomes-driven care, and for the application of personalized medicine for the treatment of respiratory disease.
One in four Americans suffer from a serious chronic or life threatening respiratory disease, from asthma and emphysema to lung cancer and cystic fibrosis. National Jewish Health is the leading and only institution dedicated to research and treatment of respiratory disease for both adults and children. The Icahn School of Medicine is ranked among the top medical schools in the United States and is the medical education and research hub for the entire Mount Sinai Health System, one of the countrys largest not-for-profit, multi-site health care systems. The Mount Sinai Pulmonary, Critical Care and Sleep Medicine division houses innovative, world class programs in sarcoidosis, lung cancer, critical care medicine, genomics and immunological sciences. Together, the Icahn School of Medicine and National Jewish Health bring an extraordinary level of world leading expertise in addressing complex respiratory illnesses.
March, 2026
Saturday
August 26,2019
Awesome Job!
We have received your appointment and will send you a confirmation to your provided email upon approval.